Core Insights - BioXcel Therapeutics is making significant progress in expanding treatment options for managing acute agitation, particularly in home settings [3] - The company has reported positive exploratory efficacy results along with primary safety data, indicating a step forward in patient care [3] Company Overview - BioXcel Therapeutics aims to transform patient care by addressing the challenges faced by patients and families dealing with acute agitation [3] - The leadership team includes Vimal Mehta as CEO, Dr. Leslie Citrome as a clinical expert, and Dusan Kostic overseeing clinical and medical affairs [2]